Vol. 1 No. 4 (2021)
Examens d’une technologie de la santé

Onabotulinum Toxin A (Botox) for Spasticity in Patients With Acquired Brain Injury

Publication : April 22, 2021

Messages clés

  • No relevant literature was identified regarding the clinical effectiveness or cost-effectiveness of onabotulinum toxin A (Botox) for reducing spasticity in patients with traumatic or non-traumatic–acquired brain injury.
  • Authors of 1 evidence-based guideline recommend the use of botulinum toxin (subtype and formulation not specified) for the treatment of spasticity associated with traumatic brain injury.